6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 18 Mar 2026
- Reporting date
- 18 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
GSK plc reports
- Company location
- London
GSK plc has filed 6,785 SEC EDGAR filings since 12 Jan 2001
SEC filing history
Showing 101-125 of 1,000 matching filings.
Per page
25
Current page
5
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 18 Mar 2026
- Reporting date
- 18 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 17 Mar 2026
- Reporting date
- 17 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 17 Mar 2026
- Reporting date
- 17 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 16 Mar 2026
- Reporting date
- 16 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
US FDA APPROVES AREXVY FOR ADULTS 18-49 AIR
- Filing date
- 13 Mar 2026
- Reporting date
- 13 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 13 Mar 2026
- Reporting date
- 13 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 12 Mar 2026
- Reporting date
- 12 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 12 Mar 2026
- Reporting date
- 12 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 11 Mar 2026
- Reporting date
- 11 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 10 Mar 2026
- Reporting date
- 10 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
BOARD COMMITTEE CHANGE
- Filing date
- 09 Mar 2026
- Reporting date
- 09 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK AND ALFASIGMA AGREE GLOBAL LINERIXIBAT RIGHTS
- Filing date
- 09 Mar 2026
- Reporting date
- 09 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 09 Mar 2026
- Reporting date
- 09 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
FILING OF GSK PLC 2025 ANNUAL REPORT ON FORM 20-F
- Filing date
- 06 Mar 2026
- Reporting date
- 06 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
IRANNOTICE
File 001-15170
IRANNOTICE
- Filing date
- 06 Mar 2026
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
20-F
File 001-15170
20-F
- Filing date
- 06 Mar 2026
- Reporting date
- 31 Dec 2025
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 06 Mar 2026
- Reporting date
- 06 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK PUBLISHES ANNUAL REPORT 2025
- Filing date
- 05 Mar 2026
- Reporting date
- 05 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 05 Mar 2026
- Reporting date
- 05 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 04 Mar 2026
- Reporting date
- 04 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 04 Mar 2026
- Reporting date
- 04 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK COMPLETES ACQUISITION OF RAPT THERAPEUTICS
- Filing date
- 03 Mar 2026
- Reporting date
- 03 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 03 Mar 2026
- Reporting date
- 03 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC TO-T/A
SC TO-T/A
- Filing date
- 03 Mar 2026
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing